Arxis is preparing its US initial public offering with a valuation that could reach $11.2bn. The company, backed by Arcline Investment Management, plans to raise up to $1.06bn by offering 37.7 million shares within a price range of $25 to $28. This move comes amid strong demand for defense-related stocks, which are perceived as more resilient in the face of geopolitical tensions.

The group designs electronic and mechanical components for the aerospace and defense industries, as well as for sectors such as medical technology. It is structured around two main divisions covering these activities. The proceeds from the offering will be used in part to reduce debt, with the remainder allocated for operational needs and general corporate purposes.

The transaction has already garnered interest from major institutional investors, including Capital International, Janus Henderson, and T. Rowe Price, who are prepared to invest up to $400m. The listing is scheduled for the Nasdaq under the ticker symbol "ARXS", with Goldman Sachs, Morgan Stanley, and Jefferies serving as lead underwriters.